“I hate the fact that it’s so hard to access quality mental health care and there are so many things that can get in the way of being able to see someone like me,” says Dr. Ali Mattu.
“Part of the problem that we’re faced within the field is that we really need to become better at identifying the factors that lead to the escalation of suicide risk,” says Dr. Randy Auerbach,
We spoke with David Hellerstein, MD, Director, Depression Evaluation Service, Columbia University Department of Psychiatry, about his Ganaxolone for postpartum depression study.
Dr. Drew Ramsey is a pioneer in the field of nutritional psychiatry, which attempts to apply what science is learning about the impact of nutrition on the brain and mental health.
Media coverage of suicide that focuses on recovery and healing has been proven to reduce risk among vulnerable members of a community—a phenomenon Dr. Madelyn Gould refers to as the “Papageno effect.”
For the last two and a half decades, Dr. J. John Mann and his collaborators have been working to characterize brain abnormalities associated with suicide.
“It’s the first time that we know what questions indicate who’s at imminent risk, the very few people who actually need a next step,” says Dr. Kelly Posner Gerstenhaber of the Columbia Protocol.
